Chemical and Structural Aspects of Ebola Virus Entry Inhibitors.

Publication Year: 2014

DOI:
10.1021/id500025n

PMCID:
PMC4426353

PMID:
25984565

Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare the following competing financial interest(s): The Albert Einstein College of Medicine has filed two patent applications on the humanized mAbs E10 and F4 discussed herein (U.S. Provisional Patent Application No. 14/291,608 and U.S. Utility Application No. 14/291,608) entitled “Therapy for Filovirus Infection” with J.C.F. and J.R.L. as two of the co-inventors."

Evidence found in paper:

"Work in our laboratory is currently funded by the National Institutes of Health (AI090249 and U19AI109762)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025